Trails Center.org

Clinical Trial Name -A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

 
Original Study ID : ACTG 392
NCT ID : NCT00000925
Brief Title : A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
Official Title : Evaluation of High Protein Supplementation in HIV-1-Positive Subjects With Stable Weight Loss
Brief Summary : The purpose of this study is to determine whether a high-quality protein food supplement will help HIV-positive patients maintain, and possibly gain, muscle mass. Many HIV-positive patients lose weight that they are then unable to regain. This may be because patients are not eating enough protein or are not eating the right kinds of protein. The protein eaten in foods (such as meat, eggs, or beans) may not be able to make up for the amount of protein lost due to HIV infection. This study gives patients high-quality protein food supplements to help them maintain and/or gain weight.
Source : National Institute of Allergy and Infectious Diseases (NIAID)
Detailed Description :
In many HIV-infected individuals with prior weight loss, the failure to regain weight and
lean tissue is at least in part the consequence of inadequate protein intake or ingestion of
a poor-quality protein rather than total caloric intake. Dietary sources of protein are
presumably inadequate to meet the high metabolic needs caused by HIV infection. To achieve a
target protein intake in the range (1.5 to 2.0 g/kg/day) demonstrated in other catabolic
diseases necessary to achieve positive nitrogen balance and to generate substantial anabolic
effects, this study will administer a supplement containing high-quality protein.

Two groups of 28 patients each are randomly chosen to receive either an oral nutritional
supplement (Optimune) containing increased amounts of high-quality protein (whey), which is
rich in cysteine and glutamine, or an isocaloric, identical-tasting supplement without added
whey protein or amino acid supplementation. Weight, body composition, anthropometry, dietary
intake, and general physical health are assessed at baseline and at Weeks 6 and 12. Plasma
cysteine, glutathione, C-reactive protein, and prealbumin, along with urine IL-6, sTNFrII,
and IL-1ra, are assessed at baseline and at Week 12.
Overall Status : Completed
Start Date : May 1999
Official Title : Phase 2
Phase : Interventional
Study Design : Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Enrollment : 56
Verification Date : June 2003
First Received Date : November 2, 1999
Trial Eligibility
Criteria :
Inclusion Criteria

You may be eligible for this study if you:

- Are HIV-positive.

- Are at least 18 years old.

- Have an HIV level less than 5,000 copies/ml within 30 days of study entry.

- Have lost weight in the past year, but your weight has remained fairly stable in the 2
months prior to enrollment.

- Are expected to live for at least 6 months.

- Are usually able to eat enough to maintain your present weight.

- Are able to complete a 3-day food diary.

Exclusion Criteria

You will not be eligible for this study if you:

- Have gained a significant amount of weight in the past 2 months.

- Have any opportunistic (HIV-associated) infections.

- Are unable to eat enough food for any reason, or are on tube feeding.

- Have nausea, diarrhea, or vomiting in the 14 days prior to study entry.

- Are being treated for diabetes.

- Are receiving chemotherapy or radiation therapy to treat cancer.

- Are pregnant or breast-feeding.

- Are allergic to milk or mangoes.

- Have an implanted defibrillator.
Gender : Both
Minimum Age : 18 Years
Maximum Age : N/A
Healthy Volunteers : No
Facilities
Facility Name : San Francisco Gen Hosp
City : San Francisco
State : California
Zip Code : 941102859
Country : United States
Facility Name : Stanford Univ Med Ctr
City : Stanford
State : California
Zip Code : 943055107
Country : United States
Facility Name : UCLA CARE Ctr
City : Los Angeles
State : California
Zip Code : 90095
Country : United States
Facility Name : Univ of Southern California / LA County USC Med Ctr
City : Los Angeles
State : California
Zip Code : 900331079
Country : United States
Facility Name : Univ of Colorado Health Sciences Ctr
City : Denver
State : Colorado
Zip Code : 80262
Country : United States
Facility Name : Queens Med Ctr
City : Honolulu
State : Hawaii
Zip Code : 96816
Country : United States
Facility Name : Univ of Hawaii
City : Honolulu
State : Hawaii
Zip Code : 96816
Country : United States
Facility Name : Tulane Univ School of Medicine
City : New Orleans
State : Louisiana
Zip Code : 70112
Country : United States
Facility Name : Johns Hopkins Hosp
City : Baltimore
State : Maryland
Zip Code : 21287
Country : United States
Facility Name : St Louis Regional Hosp / St Louis Regional Med Ctr
City : St Louis
State : Missouri
Zip Code : 63112
Country : United States
Facility Name : Univ of Rochester Medical Center
City : Rochester
State : New York
Zip Code : 14642
Country : United States
Facility Name : Cornell Univ Med Ctr
City : New York
State : New York
Zip Code : 10021
Country : United States
Facility Name : Chelsea Ctr
City : New York
State : New York
Zip Code : 10021
Country : United States
Facility Name : Univ of Cincinnati
City : Cincinnati
State : Ohio
Zip Code : 452670405
Country : United States
Facility Name : Ohio State Univ Hosp Clinic
City : Columbus
State : Ohio
Zip Code : 432101228
Country : United States
Facility Name : Philadelphia Veterans Administration Med Ctr
City : Philadelphia
State : Pennsylvania
Zip Code : 19104
Country : United States
Facility Name : Julio Arroyo
City : West Columbia
State : South Carolina
Zip Code : 29169
Country : United States
Facility Name : Univ of Washington
City : Seattle
State : Washington
Zip Code : 98104
Country : United States
Facility Name : Univ of Puerto Rico
City : San Juan
State : Washington
Zip Code : 009365067
Country : Puerto Rico
 
Search Trials By
Search
 
Research
 
 
Most Popular Trials
 
Library
 
Discuss